Broadview Analytics LLC

FOR IMMEDIATE RELEASE

[NATIONWIDE]

Broadview Analytics Encourages Eligible Individuals to Consider Neuralink Clinical Trials

Broadview Analytics LLC is encouraging eligible individuals to consider participating in clinical trials conducted by Neuralink.

As a socially responsible consulting and research firm, Broadview Analytics believes that supporting ethical medical research and public awareness can help advance healthcare and improve the lives of people with serious neurological conditions.

Current eligibility includes individuals with:

* Quadriplegia caused by spinal cord injury.
* Amyotrophic Lateral Sclerosis (ALS) with significant loss of movement or communication.

Clinical trial participation helps researchers evaluate new technologies that may restore communication and independence while contributing to future medical advances.

Broadview Analytics encourages interested individuals to review the eligibility requirements, consult their healthcare providers, and make an informed decision about participation. To learn more and sign up visit Neuralink